BGMS · XBRL financial data
Bio Green Med Solution financial statements, every quarter
The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (BGMS's year ends in late December)
| In thousands of dollars | Sep 30, 2023 | Mar 11, 2024 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | †Dec 31, 2024 | Mar 31, 2025 | †Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | year only | — | — | — | year only | 743 | 357* |
| Research and development | 5,236 | — | 2,802 | 2,023 | 950 | 880* | 822 | 68 | 5 | (47)* | — | — |
| Selling, general and administrative | 1,625 | — | 1,582 | 1,625 | 1,237 | 948* | — | — | — | — | — | — |
| General and administrative | — | — | 1,582 | 1,625 | 1,237 | 948* | 4,214 | 1,249 | 1,004 | 1,250* | 389 | 497 |
| Total operating expenses | 6,861 | — | 4,384 | 3,648 | 2,187 | 1,828* | 5,036 | 1,317 | 1,073 | 1,748* | 1,024 | 754 |
| Operating income (loss) | (6,845) | — | (4,355) | (3,644) | (2,177) | (1,828)* | (5,036) | (1,317) | (992) | (1,082)* | (246) | (418) |
| Interest income | 50 | — | 2 | — | — | year only | — | — | — | — | — | — |
| Other income (expense) | (9) | — | 52 | 0* | 0* | 0* | 10 | 2 | 9 | 333* | 31 | 31 |
| Income tax expense (benefit) | (668) | — | (1,354) | (412) | (210) | 1,194* | — | 2 | 0* | 5* | 30 | 9 |
| Net income (loss) | (6,032) | — | (2,946) | (3,257) | (1,957) | (3,052)* | (81) | (1,318) | (988) | (611)* | (197) | (405) |
| Earnings per share, basic USD per share | — | — | (2.27) | (172.18) | (43.80) | — | 0.00 | (0.98) | (1.31) | — | — | — |
| Earnings per share, diluted USD per share | — | — | (2.27) | (172.18) | (43.80) | — | 0.00 | (0.98) | (1.31) | — | — | — |
| Weighted average shares, basic thousands of shares | — | — | — | — | 45 | — | 365 | 1,361 | 1,912 | — | 5,459 | 5,599 |
| Weighted average shares, diluted thousands of shares | — | — | — | — | 45 | — | 365 | 1,361 | 1,912 | — | 5,459 | 5,599 |
- † Share count changed about 33x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/159 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal quarters (BGMS's year ends in late December)
- ‡ Per-share figures and share counts are adjusted for the 1-for-14.925373134328357 stock split (December 2023); filings made before it reported them unadjusted.
- † Share count changed about 33x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/159 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal quarters (BGMS's year ends in late December)
| In thousands of dollars | Sep 30, 2023 | Mar 11, 2024 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | †Dec 31, 2024 | Mar 31, 2025 | †Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (6,032) | — | (2,946) | (3,257) | (1,957) | (3,052)* | (81) | (1,318) | (988) | (611)* | (197) | (405) |
| Stock-based compensation | 391* | — | 203 | 189* | 107* | 93* | 1,666 | 7* | 6* | 655* | 1 | 0* |
| Net cash from operating activities | (4,036)* | — | (483) | (3,084)* | (3,067)* | (1,356)* | (3,247) | (1,056)* | (434)* | (33)* | (278) | (352)* |
| Purchases of property and equipment | 0* | — | — | — | 0* | — | — | — | — | — | 1 | 0* |
| Net cash from investing activities | 0* | — | — | — | 0* | — | — | — | — | — | (1) | 0* |
| Proceeds from issuing equity | — | — | — | — | (1)* | 0* | 3,894 | 1,673* | (3)* | 861* | 125 | 794* |
| Net cash from financing activities | (50)* | — | (79) | 6,289* | (1)* | 1,613* | 3,646 | 1,880* | (3)* | (259)* | 105 | 773* |
| Net change in cash | (4,220)* | — | (580) | 3,202* | (3,018)* | 155* | 313 | 825* | (437)* | (333)* | (166) | 451* |
- † Share count changed about 33x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/159 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 5099 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 5099 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (5099) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Bio Green Med Solution | 3,790 | 357* | (352)* | 6.6M | 10.8 quarters | 10-QJun 30, 2026 |
| Greenlane Holdings | 6,065 | 82 | (2,268)* | 694,544 | 2.7 quarters | 10-QJun 30, 2026 |
| Alliance Entertainment Holdingadded: same SIC | 814 | 500* | (9,029)* | 51.0M | 0.1 quarters | 10-KJun 30, 2026 |
| Core & Mainadded: same SIC | 312,000 | 2,145,000 | 62,000* | not reported | — | 10-QAug 2, 2026 |
| Arculus Systemadded: same SIC | 2.3 | 0 | (56)* | 4.1M | 0.0 quarters | 10-QJun 30, 2025 |
| FF Global Holdingsadded: same SIC | not reported | not reported | not reported | not reported | — | — |
| Humitech International Groupadded: same SIC | not reported | not reported | not reported | not reported | — | — |
Not investment advice. Not affiliated with the U.S. SEC.
